Trial Details
COMPLETEDBasic Information
| Clinical ID | c2444 |
|---|---|
| Identifier | NCT03476317 |
| Trial Title | Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: Vancomycin|DRUG: Neomycin|DRUG: Ciprofloxacin|DRUG: Polyethylene Glycol 3350|DRUG: Fluconazole |
Participant Information
| Sponsor | Children's Hospital of Philadelphia |
|---|---|
| City | Philadelphia |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2018-07-12 |
|---|---|
| Primary Completion Date | 2020-12-31 |
| Completion Date | 2020-12-31 |